Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders

Neuromuscular Diseases Clinical Trial

— CLASSIC  

Official title:

Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04581577
• Other study ID #: 286495
• Status: Recruiting
• Start date: September 11, 2020
• Est. completion date: April 30, 2021

Study information

• Verified date: March 2021
• Source: Royal Brompton & Harefield NHS Foundation Trust
• Contact: Lydia Spurr, MBBS
• Phone: 0207 352 8121
• Email: l.spurr[@]rbht.nhs.uk
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to evaluate perceived clinical and psychosocial experiences of patients and their families during the Covid-19 pandemic. it is important to understand the implications of the pandemic for this population, particularly given its likely protracted course, and resultant limitations to daily activities and clinical care. This will help clinicians plan support and adaptations to the services they provide in the medium to long term.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 75
• Est. completion date: April 30, 2021
• Est. primary completion date: December 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

Adult group

• Patient over 16 years of age with a confirmed diagnosis of neuromuscular and/or neurological disorder
• Able and willing to provide informed consent Paediatric group
• Parent of a patient under 16 years of age with a confirmed diagnosis of neuromuscular and/or neurological disorder
• Able and willing to provide informed consent

Exclusion Criteria:

• Unwilling for telephone questionnaire to be audio-recorded

Related Conditions & MeSH terms

• Nervous System Diseases
• Neurological Diseases or Conditions
• Neuromuscular Diseases

Intervention

Other:
• Semi-structured telephone questionnaire
Semi-structured telephone questionnaire

Locations

Country	Name	City	State
United Kingdom	Royal Brompton Hospital	London

Sponsors (1)

Lead Sponsor	Collaborator
Royal Brompton & Harefield NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Qualitative evaluation of the perceived clinical and psychosocial impact of the Covid-19 pandemic in patients with neuromuscular and neurological disorders	Evaluation of semi-structured questionnaires using thematic analysis	4 months
Secondary	Quantification of the proportion of patients with NMD who have had suspected or confirmed Covid-19 infection during the pandemic	Quantitative analysis of the proportion of questionnaire respondents reporting confirmed or suspected Covid-19 infection	4 months
Secondary	Qualitative evaluation of the social environment of patients with NMDs	Qualitative analysis describing the social environment of patients with NMDs	4 months
Secondary	Qualitative evaluation of the social activities of patients with NMDs	Qualitative analysis describing the social activities of patients with NMDs	4 months
Secondary	Qualitative evaluation of the professional activities of patients with NMDs	Qualitative analysis describing the professional activities of patients with NMDs	4 months
Secondary	Qualitative evaluation of the impact of the Covid-19 pandemic on families of patients with neuromuscular and neurological disorders	Evaluation of semi-structured questionnaires using thematic analysis	4 months
Secondary	Qualitative evaluation of concerns regarding medical care from the perspective of patients with NMDs and their families during the Covid-19 pandemic	Evaluation of semi-structured questionnaires using thematic analysis	4 months